Dyadic International, Inc. (OTCQX: DYAI) is a global biotechnology company focused on further improving and leveraging the patented and proprietary C1 expression system to help bring biologic vaccines and drugs to market faster, in greater volumes, at lower cost, and with new properties to drug developers and manufacturers to improve access and cost to patients and the healthcare system - but most importantly to save lives.
Parabon Computation operates as a biotechnology research company. The Company offers bioinformatics, data mining, snapshot genetic geneal...
Reliable Biopharmaceutical Corporation manufactures of industrial organic chemicals. The Company offers pharmaceutical ingredients. Relia...
Molecular Sensing is a medical organization currently based in Nashville, Tennessee, United States. It has been founded in 2007.
SABiosciences Corporation, founded in 1998, is a privately held biotechnology company. Their founders envisioned a new, more systematic a...
Bioneer Corporation provides molecular biology products. The Company develops oligo synthesis, nucleic acid amplication enzymes, and othe...
Nektar Therapeutics develops therapeutics based on its advanced polymer conjugate chemistry technology platform.